临床反应-话题@MedSci

#临床反应#

11篇内容 | 369人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1797340, encodeId=70011e9734019, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Molecular Psychiatry:内侧前脑束上外侧支深部脑刺激治疗难治性抑郁症后的代谢变化与临床反应相关, objectType=article, longId=737022, objectId=768fe3702251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768fe3702251, replyNumber=0, likeNumber=37, createdTime=2022-10-12, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768fe3702251, moduleTitle=Molecular Psychiatry:内侧前脑束上外侧支深部脑刺激治疗难治性抑郁症后的代谢变化与临床反应相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=768fe3702251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797341, encodeId=cadc1e97341d7, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle= Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应, objectType=article, longId=739092, objectId=578de3909292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=578de3909292, replyNumber=0, likeNumber=44, createdTime=2022-09-13, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=578de3909292, moduleTitle= Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=578de3909292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797339, encodeId=9af61e973397d, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=J Clin Oncol：溶瘤柯萨奇病毒A21(V937)治疗不可切除的黑色素瘤的临床反应和安全性, objectType=article, longId=216578, objectId=b7f12165e835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7f12165e835, replyNumber=0, likeNumber=53, createdTime=2022-08-02, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7f12165e835, moduleTitle=J Clin Oncol：溶瘤柯萨奇病毒A21(V937)治疗不可切除的黑色素瘤的临床反应和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7f12165e835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797338, encodeId=29a41e9733892, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=IBD：克罗恩病患者的内镜活动和基线血清TNF-α水平与乌司奴单抗的临床反应相关, objectType=article, longId=202491, objectId=3150202491ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3150202491ad, replyNumber=0, likeNumber=35, createdTime=2021-10-10, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3150202491ad, moduleTitle=IBD：克罗恩病患者的内镜活动和基线血清TNF-α水平与乌司奴单抗的临床反应相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3150202491ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797337, encodeId=942b1e97337c5, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, objectType=article, longId=188594, objectId=2de618859436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de618859436, replyNumber=0, likeNumber=39, createdTime=2020-12-30, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de618859436, moduleTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de618859436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797336, encodeId=999c1e9733632, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Inflam Bowel Dis： Golimumab的连续临床反应与重度溃疡性结肠炎患者病程变化相关, objectType=article, longId=157181, objectId=341f15e18134, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=341f15e18134, replyNumber=0, likeNumber=26, createdTime=2019-08-19, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=341f15e18134, moduleTitle=Inflam Bowel Dis： Golimumab的连续临床反应与重度溃疡性结肠炎患者病程变化相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=341f15e18134)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797335, encodeId=0a9a1e9733587, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=CLIN CANCER RES：IFNγ+T细胞增加与低剂量地西他滨抗肿瘤治疗临床反应有关, objectType=article, longId=117965, objectId=458811e96533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=458811e96533, replyNumber=0, likeNumber=41, createdTime=2018-04-22, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=458811e96533, moduleTitle=CLIN CANCER RES：IFNγ+T细胞增加与低剂量地西他滨抗肿瘤治疗临床反应有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=458811e96533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797334, encodeId=41741e973343d, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, objectType=article, longId=114676, objectId=4ab01146e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab01146e693, replyNumber=0, likeNumber=42, createdTime=2018-04-07, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab01146e693, moduleTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ab01146e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797333, encodeId=2a981e9733320, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Heart：静脉血栓栓塞症患者对华法林和依度沙班的遗传学和临床反应！, objectType=article, longId=105175, objectId=de921051e512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de921051e512, replyNumber=0, likeNumber=27, createdTime=2018-06-20, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de921051e512, moduleTitle=Heart：静脉血栓栓塞症患者对华法林和依度沙班的遗传学和临床反应！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de921051e512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797332, encodeId=af5a1e9733223, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Lancet：Dupilumab可以改善中-重度特应性皮炎患者临床反应, objectType=article, longId=56994, objectId=44345699436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44345699436, replyNumber=0, likeNumber=38, createdTime=2016-06-02, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44345699436, moduleTitle=Lancet：Dupilumab可以改善中-重度特应性皮炎患者临床反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44345699436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797331, encodeId=fe581e9733137, content=<a href='/topic/show?id=0eae22e401d' target=_blank style='color:#2F92EE;'>#临床反应#</a>, objectTitle=Immunity：补体是放疗诱导的特异性肿瘤免疫和临床反应的中央介质, objectType=article, longId=49774, objectId=bccf49e74c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bccf49e74c4, replyNumber=0, likeNumber=33, createdTime=2015-07-07, rootId=0, userName=cooco, userId=cbcc223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bccf49e74c4, moduleTitle=Immunity：补体是放疗诱导的特异性肿瘤免疫和临床反应的中央介质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bccf49e74c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

临床反应

2020-05-29

cooco (审核中...)

前往app查看评论内容

#临床反应#

Molecular Psychiatry:内侧前脑束上外侧支深部脑刺激治疗难治性抑郁症后的代谢变化与临床反应相关

2022-10-12

cooco (审核中...)

前往app查看评论内容

#临床反应#

Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应

2022-09-13

cooco (审核中...)

前往app查看评论内容

#临床反应#

J Clin Oncol：溶瘤柯萨奇病毒A21(V937)治疗不可切除的黑色素瘤的临床反应和安全性

2022-08-02

cooco (审核中...)

前往app查看评论内容

#临床反应#

IBD：克罗恩病患者的内镜活动和基线血清TNF-α水平与乌司奴单抗的临床反应相关

2021-10-10

cooco (审核中...)

前往app查看评论内容

#临床反应#

J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化

2020-12-30

cooco (审核中...)

前往app查看评论内容

#临床反应#

Inflam Bowel Dis： Golimumab的连续临床反应与重度溃疡性结肠炎患者病程变化相关

2019-08-19

cooco (审核中...)

前往app查看评论内容

#临床反应#

CLIN CANCER RES：IFNγ+T细胞增加与低剂量地西他滨抗肿瘤治疗临床反应有关

2018-04-22

cooco (审核中...)

前往app查看评论内容

#临床反应#

Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。

2018-04-07

cooco (审核中...)

前往app查看评论内容

#临床反应#

Heart：静脉血栓栓塞症患者对华法林和依度沙班的遗传学和临床反应！

2018-06-20

cooco (审核中...)

前往app查看评论内容

#临床反应#

Lancet：Dupilumab可以改善中-重度特应性皮炎患者临床反应

2016-06-02

cooco (审核中...)

前往app查看评论内容

#临床反应#

Immunity：补体是放疗诱导的特异性肿瘤免疫和临床反应的中央介质

2015-07-07

科室
- - 订阅+
  - 更多科室
工具
服务